Interferon-Gamma Producing Regulatory T Cells as a Diagnostic and Therapeutic Tool in Organ Transplantation

REFERENCES

• Sakaguchi S, Miyara M, Costantino CM, Hafler DA. FOXP3+ regulatory T cells in the human immune system. Nat Rev Immunol 2010;10(7):490–500.
   PubMed Web of Science ®Google Scholar
• Bluestone JA, Mackay CR, O'Shea JJ, Stockinger B. The functional plasticity of T cell subsets. Nat Rev Immunol 2009;9(11):811–816.
   PubMed Web of Science ®Google Scholar
• Zhu J, Paul WE. Heterogeneity and plasticity of T helper cells. Cell Res 2010;20(1):4–12.
   PubMed Web of Science ®Google Scholar
• Putnam AL, Vendrame F, Dotta F, Gottlieb PA. CD4+CD25high regulatory T cells in human autoimmune diabetes. J Autoimmun 2005;24(1):55–62.
   PubMed Web of Science ®Google Scholar
• Gregg R, Smith CM, Clark FJ, The number of human peripheral blood CD4+ CD25high regulatory T cells increases with age. Clin Exp Immunol 2005;140(3):540–546.
   PubMed Web of Science ®Google Scholar
• Baecher-Allan CM, Hafler DA. The purification and functional analysis of human CD4+CD25high regulatory T cells. Curr Protoc Immunol 2006; Chapter 7:Unit 7 4B.
   PubMedGoogle Scholar
• Baecher-Allan C, Brown JA, Freeman GJ, Hafler DA. CD4+CD25high regulatory cells in human peripheral blood. J Immunol 2001;167(3):1245–1253.
   PubMed Web of Science ®Google Scholar
• Liu W, Putnam AL, Xu-Yu Z, CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells. J Exp Med 2006;203(7):1701–1711.
   PubMed Web of Science ®Google Scholar
• Miyara M, Yoshioka Y, Kitoh A, Functional delineation and differentiation dynamics of human CD4 +T cells expressing the FoxP3 transcription factor. Immunity 2009;30(6):899–911.
   PubMed Web of Science ®Google Scholar
• Maloy KJ, Powrie F. Fueling regulation: IL-2 keeps CD4+ Treg cells fit. Nat Immunol 2005;6(11):1071–1072.
   PubMed Web of Science ®Google Scholar
• Tran DQ. TGF-beta: the sword, the wand, and the shield of FOXP3(+) regulatory T cells. J Mol Cell Biol 2012;4(1):29–37.
   PubMed Web of Science ®Google Scholar
• Sakaguchi S, Wing K, Onishi Y, Regulatory T cells: how do they suppress immune responses? Int Immunol 2009;21(10):1105–1111.
   PubMed Web of Science ®Google Scholar
• Vignali DA, Collison LW, Workman CJ. How regulatory T cells work. Nat Rev Immunol 2008;8(7):523–532.
   PubMed Web of Science ®Google Scholar
• Sakaguchi S, Yamaguchi T, Nomura T, Ono M. Regulatory T cells and immune tolerance. Cell 2008;133(5):775–787.
   PubMed Web of Science ®Google Scholar
• Shevach EM. Mechanisms of foxp3+ T regulatory cell-mediated suppression. Immunity 2009;30(5):636–645.
   PubMed Web of Science ®Google Scholar
• Tang Q, Bluestone JA. The Foxp3+ regulatory T cell: a jack of all trades, master of regulation. Nat Immunol 2008;9(3):239–244.
   PubMed Web of Science ®Google Scholar
• Horwitz DA, Zheng SG, Wang J, Gray JD. Critical role of IL-2 and TGF-beta in generation, function and stabilization of Foxp3+CD4+ Treg. Eur J Immunol 2008;38(4):912–915.
   PubMed Web of Science ®Google Scholar
• Dobrzanski MJ, Rewers-Felkins KA, Samad KA, Quinlin IS, Immunotherapy with IL-10- and IFN-gamma-producing CD4 effector cells modulate “Natural” and “Inducible” CD4 TReg cell subpopulation levels: observations in four cases of patients with ovarian cancer. Cancer Immunol Immunother 2012;61(6):839–854.
   PubMed Web of Science ®Google Scholar
• Schmidt A, Oberle N, Krammer PH. Molecular mechanisms of treg-mediated T cell suppression. Front Immunol 2012;3:51.
   Google Scholar
• Jordan MS, Boesteanu A, Reed AJ, Thymic selection of CD4+CD25+ regulatory T cells induced by an agonist self-peptide. Nat Immunol 2001;2(4):301–306.
   PubMed Web of Science ®Google Scholar
• Karim M, Kingsley CI, Bushell AR, Alloantigen-induced CD25+CD4+ regulatory T cells can develop in vivo from CD25-CD4+ precursors in a thymus-independent process. J Immunol 2004;172(2):923–928.
   PubMed Web of Science ®Google Scholar
• Tang Q, Bluestone JA, Kang SM. CD4(+)Foxp3(+) regulatory T cell therapy in transplantation. J Mol Cell Biol 2012;4(1):11–21.
   Google Scholar
• Lan Q, Fan H, Quesniaux V. Induced Foxp3(+) regulatory T cells: a potential new weapon to treat autoimmune and inflammatory diseases? J Mol Cell Biol 2011;4(1):22–28.
   Google Scholar
• Li CR, Baaten BJ, Bradley LM. Harnessing memory adaptive regulatory T cells to control autoimmunity in type 1 diabetes. J Mol Cell Biol 2012;4(1):38–47.
   Google Scholar
• Brunstein CG, Miller JS, Cao Q, Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics. Blood 2011;117(3):1061–1070.
   PubMed Web of Science ®Google Scholar
• Klein S, Kretz CC, Krammer PH, Kuhn A. CD127(low/−) and FoxP3(+) expression levels characterize different regulatory T-cell populations in human peripheral blood. J Invest Dermatol 2010;130(2):492–499.
   Google Scholar
• Juvet SC, Zhang L. Double negative regulatory T cells in transplantation and autoimmunity: recent progress and future directions. J Mol Cell Biol 2012;4(1):48–58.
   PubMed Web of Science ®Google Scholar
• Thornton AM, Shevach EM. CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J Exp Med 1998;188(2):287–296.
   PubMed Web of Science ®Google Scholar
• Chen W, Konkel JE. TGF-beta and ‘adaptive’ Foxp3(+) regulatory T cells. J Mol Cell Biol 2010;2(1):30–36.
   PubMed Web of Science ®Google Scholar
• Fiorentino DF, Bond MW, Mosmann TR. Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med 1989;170(6):2081–2095.
   PubMed Web of Science ®Google Scholar
• Sad S, Mosmann TR. Single IL-2-secreting precursor CD4 T cell can develop into either Th1 or Th2 cytokine secretion phenotype. J Immunol 1994;153(8):3514–3522.
   PubMed Web of Science ®Google Scholar
• Kehrl JH, Wakefield LM, Roberts AB, Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growth. J Exp Med 1986;163(5):1037–1050.
   PubMed Web of Science ®Google Scholar
• Hill JA, Hall JA, Sun CM, Retinoic acid enhances Foxp3 induction indirectly by relieving inhibition from CD4+CD44hi Cells. Immunity 2008;29(5):758–770.
   PubMed Web of Science ®Google Scholar
• Feng G, Wood KJ, Bushell A. Interferon-gamma conditioning ex vivo generates CD25+CD62L+Foxp3 +regulatory T cells that prevent allograft rejection: potential avenues for cellular therapy. Transplantation 2008;86(4):578–589.
   Google Scholar
• Hall BM, Verma ND, Tran GT, Hodgkinson SJ. Distinct regulatory CD4+T cell subsets; differences between naive and antigen specific T regulatory cells. Curr Opin Immunol 2011;23(5):641–647.
   Google Scholar
• Sawitzki B, Kingsley CI, Oliveira V, IFN-gamma production by alloantigen-reactive regulatory T cells is important for their regulatory function in vivo. J Exp Med 2005;201(12):1925–1935.
   Google Scholar
• Wood KJ, Sawitzki B. Interferon gamma: a crucial role in the function of induced regulatory T cells in vivo. Trends Immunol 2006;27(4):183–187.
   Google Scholar
• Daniel V, Naujokat C, Sadeghi M, Observational support for an immunoregulatory role of CD3+CD4+CD25+IFN-gamma+ blood lymphocytes in kidney transplant recipients with good long-term graft outcome. Transpl Int 2008;21(7):646–660.
   Google Scholar
• Stroopinsky D, Avivi I, Rowe JM, Allogeneic induced human FOXP3(+)IFN-gamma(+) T cells exhibit selective suppressive capacity. Eur J Immunol 2009;39(10):2703–2715.
   Google Scholar
• Daniel V, Sadeghi M, Wang H, Opelz G. CD4+CD25+Foxp3+IFN-gamma+ human induced T regulatory cells are induced by interferon-gamma and suppress alloresponses nonspecifically. Hum Immunol 2011;72(9):699–707.
   Google Scholar
• Chowdary Venigalla RK, Guttikonda PJ, Eckstein V, Identification of a human Th1-like IFNgamma-secreting Treg subtype deriving from effector T cells. J Autoimmun 2012;39(4):377–387.
   Google Scholar
• Daniel V, Sadeghi M, Wang H, Opelz G. CD4(+)CD25(+)Foxp3(+)IFNgamma(+) Treg are immunosuppressive in vitro and increase with intensity of the alloresponse in pretransplant MLC. Transpl Immunol 2012;27(2–3):114–121.
   Google Scholar
• Dominguez-Villar M, Baecher-Allan CM, Hafler DA. Identification of T helper type 1-like, Foxp3 +regulatory T cells in human autoimmune disease. Nat Med 2011;17(6):673–675.
   PubMed Web of Science ®Google Scholar
• Ferraris J, Tambutti M, Prigoshin N. Improved long-term graft function in kidney transplant recipients with donor antigen-specific hyporeactivity. Pediatr Transplant 2007;11(2):139–144.
   Google Scholar
• Reinsmoen NL, Matas AJ. Evidence that improved late renal transplant outcome correlates with the development of in vitro donor antigen-specific hyporeactivity. Transplantation 1993; 55(5):1017–1023.
   Google Scholar
• Harmon WE, Parkman R, Lavin PT, Comparison of cell-mediated lympholysis and mixed lymphocyte culture in the immunologic evaluation for renal transplantation. J Immunol 1982;129(4):1573–1577.
   Google Scholar
• Ringden O, Berg B. Correlation between magnitude of MLC and kidney graft survival in intrafamilial transplantation. Tissue Antigens 1977;10(5):364–372.
   Google Scholar
• Solheim BG, Flatmark A, Enger E, Influence of HLA-A, -B, -C, and -D matching on the outcome of clinical kidney transplantation. Transplant Proc 1977;9(1):475–478.
   Google Scholar
• Floess S, Freyer J, Siewert C, Epigenetic control of the foxp3 locus in regulatory T cells. PLoS Biol 2007;5(2):e38.
   PubMed Web of Science ®Google Scholar
• Wieczorek G, Asemissen A, Model F, Quantitative DNA methylation analysis of FOXP3 as a new method for counting regulatory T cells in peripheral blood and solid tissue. Cancer Res 2009;69(2):599–608.
   PubMed Web of Science ®Google Scholar
• Polansky JK, Kretschmer K, Freyer J, DNA methylation controls Foxp3 gene expression. Eur J Immunol 2008;38(6):1654–1663.
   PubMed Web of Science ®Google Scholar
• McClymont SA, Putnam AL, Lee MR, Plasticity of human regulatory T cells in healthy subjects and patients with type 1 diabetes. J Immunol 2011;186(7):3918–3926.
   PubMed Web of Science ®Google Scholar
• Thornton AM, Korty PE, Tran DQ, Expression of Helios, an Ikaros transcription factor family member, differentiates thymic-derived from peripherally induced Foxp3+ T regulatory cells. J Immunol 2010;184(7):3433–3441.
   PubMed Web of Science ®Google Scholar
• Daniel V, Sadeghi M, Wang H, Opelz G. CD4(+)CD25(+)Foxp3(+)IFNgamma(+)CD178(+) human induced Treg (iTreg) contribute to suppression of alloresponses by apoptosis of responder cells. Hum Immunol 2013;74(2):151–162.
   Google Scholar
• Daniel V, Sadeghi M, Wang H, Opelz G. In-vitro inhibition of IFNgamma+ iTreg mediated by monoclonal antibodies against cell surface determinants essential for iTreg function. BMC Immunol 2012;13:47.
   PubMed Web of Science ®Google Scholar
• Zheng J, Liu Y, Qin G, Generation of human Th1-like regulatory CD4+ T cells by an intrinsic IFN-gamma- and T-bet-dependent pathway. Eur J Immunol 2010;41(1):128–139.
   Google Scholar
• Szabo SJ, Kim ST, Costa GL, A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 2000;100(6):655–669.
   PubMed Web of Science ®Google Scholar
• Amsen D, Spilianakis CG, Flavell RA. How are T(H)1 and T(H)2 effector cells made? Curr Opin Immunol 2009;21(2):153–160.
   Google Scholar
• Beima KM, Miazgowicz MM, Lewis MD, T-bet binding to newly identified target gene promoters is cell type-independent but results in variable context-dependent functional effects. J Biol Chem 2006;281(17):11992–12000.
   Google Scholar
• Bonecchi R, Bianchi G, Bordignon PP, Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. J Exp Med 1998;187(1):129–134.
   PubMed Web of Science ®Google Scholar
• Chen W, Liang X, Peterson AJ, The indoleamine 2,3-dioxygenase pathway is essential for human plasmacytoid dendritic cell-induced adaptive T regulatory cell generation. J Immunol 2008;181(8):5396–5404.
   PubMed Web of Science ®Google Scholar
• Takikawa O, Habara-Ohkubo A, Yoshida R. IFN-gamma is the inducer of indoleamine 2,3-dioxygenase in allografted tumor cells undergoing rejection. J Immunol 1990;145(4):1246–1250.
   Google Scholar
• Wei B, Baker S, Wieckiewicz J, Wood KJ. IFN-gamma triggered STAT1-PKB/AKT signalling pathway influences the function of alloantigen reactive regulatory T cells. Am J Transplant 2010;10(1):69–80.
   PubMed Web of Science ®Google Scholar
• Wang Z, Hong J, Sun W, Role of IFN-gamma in induction of Foxp3 and conversion of CD4 +CD25- T cells to CD4+ Tregs. J Clin Invest 2006;116(9):2434–2441.
   PubMed Web of Science ®Google Scholar
• Feng G, Gao W, Strom TB, Exogenous IFN-gamma ex vivo shapes the alloreactive T-cell repertoire by inhibition of Th17 responses and generation of functional Foxp3 +regulatory T cells. Eur J Immunol 2008;38(9):2512–2527.
   Google Scholar
• Feng G, Wood KJ, Bushell A. Regulatory T cell enrichment by IFN-gamma conditioning. Methods Mol Biol 2011;677:281–301.
   Google Scholar
• Warnecke G, Feng G, Goto R, CD4+ regulatory T cells generated in vitro with IFN-{gamma} and allogeneic APC inhibit transplant arteriosclerosis. Am J Pathol 2010;177(1):464–472.
   Google Scholar
• Hoffmann P, Boeld TJ, Eder R, Loss of FOXP3 expression in natural human CD4+CD25 +regulatory T cells upon repetitive in vitro stimulation. Eur J Immunol 2009;39(4):1088–1097.
   PubMed Web of Science ®Google Scholar
• Putnam AL, Brusko TM, Lee MR, Expansion of human regulatory T-cells from patients with type 1 diabetes. Diabetes 2009;58(3):652–662.
   PubMed Web of Science ®Google Scholar
• Hoffmann P, Eder R, Boeld TJ, Only the CD45RA +subpopulation of CD4+CD25high T cells gives rise to homogeneous regulatory T-cell lines upon in vitro expansion. Blood 2006;108(13):4260–4267.
   Google Scholar
• Esposito M, Ruffini F, Bergami A, IL-17- and IFN-gamma-secreting Foxp3+ T cells infiltrate the target tissue in experimental autoimmunity. J Immunol 2010;185(12):7467–7473.
   Google Scholar
• O'Connor RA, Leech MD, Suffner J, Myelin-reactive, TGF-beta-induced regulatory T cells can be programmed to develop Th1-like effector function but remain less proinflammatory than myelin-reactive Th1 effectors and can suppress pathogenic T cell clonal expansion in vivo. J Immunol 2010;185(12):7235–7243.
   Google Scholar
• Zhou X, Bailey-Bucktrout SL, Jeker LT, Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo. Nat Immunol 2009;10(9):1000–1007.
   PubMed Web of Science ®Google Scholar
• Oldenhove G, Bouladoux N, Wohlfert EA, Decrease of Foxp3 +Treg cell number and acquisition of effector cell phenotype during lethal infection. Immunity 2009;31(5):772–786.
   Google Scholar
• Duarte JH, Zelenay S, Bergman ML, Natural Treg cells spontaneously differentiate into pathogenic helper cells in lymphopenic conditions. Eur J Immunol 2009;39(4):948–955.
   PubMedGoogle Scholar
• Tsuji M, Komatsu N, Kawamoto S, Preferential generation of follicular B helper T cells from Foxp3+ T cells in gut Peyer's patches. Science 2009;323(5920):1488–1492.
   PubMed Web of Science ®Google Scholar
• Baban B, Chandler PR, Sharma MD, IDO activates regulatory T cells and blocks their conversion into Th17-like T cells. J Immunol 2009;183(4):2475–2483.
   PubMed Web of Science ®Google Scholar
• Mellor AL, Munn DH. Physiologic control of the functional status of Foxp3+ regulatory T cells. J Immunol 2011;186(8):4535–4540.
   PubMed Web of Science ®Google Scholar
• Koch MA, Tucker-Heard G, Perdue NR, The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation. Nat Immunol 2009;10(6):595–602.
   PubMed Web of Science ®Google Scholar
• Nagar M, Vernitsky H, Cohen Y, Epigenetic inheritance of DNA methylation limits activation-induced expression of FOXP3 in conventional human CD25-CD4+ T cells. Int Immunol 2008;20(8):1041–1055.
   Google Scholar
• Stock P, Akbari O, Berry G, Induction of T helper type 1-like regulatory cells that express Foxp3 and protect against airway hyper-reactivity. Nat Immunol 2004;5(11):1149–1156.
   Google Scholar
• Zhao J, Fett C, Trandem K, IFN-gamma- and IL-10-expressing virus epitope-specific Foxp3(+) T reg cells in the central nervous system during encephalomyelitis. J Exp Med 2011;208(8):1571–1577.
   PubMed Web of Science ®Google Scholar
• Feng T, Cao AT, Weaver CT, Interleukin-12 converts Foxp3+ regulatory T cells to interferon-gamma-producing Foxp3+ T cells that inhibit colitis. Gastroenterology 2011;140(7):2031–2043.
   Google Scholar
• Koenecke C, Lee CW, Thamm K, IFN-gamma production by allogeneic Foxp3+ regulatory T cells is essential for preventing experimental graft-versus-host disease. J Immunol 2012;189(6):2890–2896.
   Google Scholar